Search Results

By Syed Ali Abutalib, MD, and Amer M. Zeidan, MBBS, MHS  / November 25, 2023

Updates in Lower-Risk Myelodysplastic Syndromes/Neoplasms

  Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic stem cell disorders that are characterized by ineffective hematopoiesis, resulting in cytopenias, and they carry a risk of progression to acute myeloid leukemia (AML). In 2022, the fifth edition of the World Health ...